ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018

Tyrosine Kinase Inhibitors Increase MCL1 Degradation and in Combination with BCLXL/BCL2 Inhibitors Drive Prostate Cancer Apoptosis.

Seiji Arai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.